Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Simiyon, Manjula, Prabha S. Chandra, and Geetha Desai. "Sexual dysfunction among women with Schizophrenia—A cross sectional study from India." Asian journal of psychiatry 24 (2016): 93-98.

Matias, Carla SF. "Correlates and predictors of nonclinical paranoia." PhD diss., Royal Holloway, University of London, 2015.

Östman, Margareta. "Low satisfaction with sex life among people with severe mental illness living in a community." Psychiatry Research 216, no. 3 (2014): 340-345.

Helleberg, Marie, Marianne G. Pedersen, Carsten B. Pedersen, Preben B. Mortensen, and Niels Obel. "Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: a nationwide population-based cohort study in Denmark." The Lancet HIV 2, no. 8 (2015): e344-e350.

Shin, Wonsuk, Minji Bang, Anhye Kim, Doo-Yeoun Cho, and Sang-Hyuk Lee. "Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia." npj Schizophrenia 7, no. 1 (2021): 1-7.

Carvalho, Célia, Carolina Motta, José Pinto-Gouveia, and Ermelindo Bernardo Peixoto. "Hallucinatory Activity in Schizophrenia: The Relationship with Childhood Memories, Submissive Behavior, Social Comparison, and Depression." World Academy of Science, International Journal of Medical, Health Biomedical, Bioengineering and Pharmaceutical Engineering 9, no. 5) (2015): 401-409.

Alahdab, Fares, Omar Alhalabi, Ghaith Attwa, Ghaith Mousa Basha, and Clive E. Adams. "Olanzapine discontinuation for schizophrenia." Cochrane Database of Systematic Reviews 3 (2012).

Basson, Rosemary, and Thea Gilks. "Women’s sexual dysfunction associated with psychiatric disorders and their treatment." Women's Health 14 (2018): 1745506518762664.

de Boer, Marrit K., Stynke Castelein, Durk Wiersma, Robert A. Schoevers, and Henderikus Knegtering. "The facts about sexual (Dys) function in schizophrenia: an overview of clinically relevant findings." Schizophrenia bulletin 41, no. 3 (2015): 674-686.

Carvalho, Célia Barreto, Carolina da Motta, José Pinto?Gouveia, and Ermelindo Peixoto. "Psychosocial roots of paranoid ideation: The role of childhood experiences, social comparison, submission, and shame." Clinical psychology & psychotherapy 25, no. 5 (2018): 650-661.

Jafari, Somayeh. "Design, Synthesis, and Pharmacological Evaluation of Novel Antipsychotic Drugs Based on Olanzapine That Display Reduced Weight Gain and Metabolic Side Effects." (2012).

Sousa, Marina, Célia Barreto Carvalho, Carolina Motta, Joana Cabral, Vera Pereira, Suzana Nunes Caldeira, and Ermelindo Peixoto. "Characterization and predictors of paranoid ideation in youths." World Academy of Science, Engineering and Technology, International Science Index 101, International Journal of Social, Behavioral, Educational, Economic and Management Engineering 9, no. 5 (2015): 1665-1672.

Carvalho, Célia Barreto, Carolina da Motta, José Pinto?Gouveia, and Ermelindo Peixoto. "Influence of family and childhood memories in the development and manifestation of paranoid ideation." Clinical psychology & psychotherapy 23, no. 5 (2016): 397-406.

Chanda, Chandrasekhar, and Sobhitha Surepalli. "Dopaminergic dysfunction in neuropsychiatric disorders. Pathophysiology, current therapeutics, and future perspectives." Neuropsychiatry & Neuropsychology/Neuropsychiatria i Neuropsychologia 14 (2019).

Singh, Shalu, Alka Bali, and Tania Peshin. "Synthesis and Evaluation of Aryl Substituted Propyl Piperazines for Potential Atypical Antipsychotic Activity." Medicinal Chemistry 17, no. 5 (2021): 429-441.

Venegas, Alexandra, Lindsay R. Meredith, Ziva D. Cooper, Brandon Towns, and Lara A. Ray. "Inclusion of cannabis users in alcohol research samples: screening in, screening out, and implications." Alcohol and alcoholism 55, no. 4 (2020): 416-423.

Ciruela, Francisco, Víctor Fernández-Dueñas, Xavier Altafaj, Fernando Contreras, Antoni Vallano, José Manuel Menchón, and Marta Valle-León. "The adenosinergic system in the neurobiology of schizophrenia: Prospective adenosine receptor–based pharmacotherapy." In Psychiatry and Neuroscience Update-Vol. II, pp. 405-419. Springer, Cham, 2017.

Shields, Gemma E., Elizabeth Camacho, Tracey Farragher, Paul Clarkson, Arpana Verma, and Linda M. Davies. "Acknowledging Patient Heterogeneity in Economic Evaluations in Schizophrenia: A Systematic Review." Value in Health (2021).

Bordet, R. "Quels critères pour un traitement antipsychotique idéal?." L'Encéphale 41, no. 1 (2015): 39-46.

Herpertz, Julian, Maike F. Richter, Carlotta Barkhau, Michael Storck, Rogério Blitz, Lavinia A. Steinmann, Janik Goltermann et al. "Symptom Monitoring based on Digital Data Collection During Inpatient Treatment of Schizophrenia Spectrum Disorders-a Feasibility Study." medRxiv (2021).